AVSFY yields 5.78% · JNJ yields 2.13%● Live data
📍 AVSFY pulled ahead of the other in Year 1
Combined, AVSFY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVSFY + JNJ for your $10,000?
AVI Limited, together with its subsidiaries, manufactures, processes, markets, and distributes branded consumer products in the food, beverage, footwear, apparel, and cosmetics sectors in South Africa and internationally. It operates through Entyce Beverages, Snackworks, I&J, Personal Care, and Footwear & Apparel segments. The company provides hot beverages, such as tea, coffee, and creamer; sweet and savoury biscuits; baked and fried potato and maize snacks; frozen convenience foods; out-of-home ranges; personal care products, including body spray, fragrance, cosmetics, and body lotion products; footwear and accessories; and fashion apparels. It offers beverages under the Five Roses, Freshpak, Trinco, Ellis Brown, Frisco, House of Coffees, Koffiehuis, Ciro, and Lavazza brands; biscuits and snacks under the Bakers, Willards, Baker Street, and ProVita brands; frozen foods under the I&J brand; and personal care products under the Yardley and Lenthéric brands. The company also provides fashion products under the Spitz, Kurt Geiger, Lacoste, Carvela, Tosoni, Gant, Green Cross, and GX&Co brands. AVI Limited is based in Johannesburg, South Africa.
Full AVSFY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.